Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
about
In vitro-in vivo correlation for complex non-oral drug products: Where do we stand?Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.Preparation and in vitro characterization of dexamethasone-loaded poly(D,L-lactic acid) microspheres embedded in poly(ethylene glycol)-poly({varepsilon}-caprolactone)-poly(ethylene glycol) hydrogel for orthopedic tissue engineering.Development and assessment of countermeasure formulations for treatment of lung injury induced by chlorine inhalationAtypical antipsychotics: trends in analysis and sample preparation of various biological samples.Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia.Particles from preformed polymers as carriers for drug delivery.PLGA-Listeriolysin O microspheres: Opening the gate for cytosolic delivery of cancer antigens.Formulation of sustained-release microspheres of granulocyte macrophage colony stimulating factor by freezing-induced phase separation with dextran and encapsulation with blended polymers.In vitro–in vivo correlation from lactide-co-glycolide polymeric dosage forms.Preparation of a reproducible long-acting formulation of risperidone-loaded PLGA microspheres using microfluidic method.Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations
P2860
Q28080736-7872B63F-8DD2-46D1-B78F-193D3D753A10Q34038697-0AE2A17A-92D7-4E15-8371-71124BE71E4AQ34259149-BBFD986E-1603-4611-BA5D-89274A05E339Q36767721-CAD2B7E7-1DA9-428F-A6C8-0664F38D65E1Q38005440-A995F606-B88F-43EA-9A81-071CED085238Q38094683-AB2203C6-99B6-4B09-9646-181A24759879Q38594961-81C7187C-E36B-4CF1-B863-8FCFA64613BFQ38793294-AF1BBA26-EEBC-4A3D-BFDA-E75FC25D2785Q39463985-1061B51C-9D1B-4A60-A6C2-69E157B04E99Q49707213-32F39138-DC6C-489C-BCA1-14AAC5BC6632Q51214293-ED41A2B8-07A2-4FEE-9626-783B6DBD8E76Q58784003-5D68E012-7BA5-4D16-A70E-936940321C23
P2860
Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@ast
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@en
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@nl
type
label
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@ast
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@en
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@nl
prefLabel
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@ast
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@en
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@nl
P2093
P356
P1476
Effects of formulation paramet ...... ide-co-glycolide) microsphere.
@en
P2093
Chaojun Jiang
Fengying Sun
Lirong Teng
Qingfan Meng
Zhengxing Su
P304
P356
10.1248/CPB.57.1251
P407
P577
2009-11-01T00:00:00Z